S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NYSE:ENFN

Enfusion News Headlines

$9.51
+0.42 (+4.62%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.91
$9.52
50-Day Range
$8.40
$15.45
52-Week Range
$7.80
$23.21
Volume
368,118 shs
Average Volume
330,473 shs
Market Capitalization
$1.08 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Enfusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Enfusion Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENFN
News Sentiment

0.07

0.32

Average
Computer and Technology
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENFN Articles
This Week

6

1

ENFN Articles
Average Week



Enfusion (NYSE:ENFN) News Headlines Today

SourceHeadline
marketbeat.com logo$35.50 Million in Sales Expected for Enfusion, Inc. (NYSE:ENFN) This Quarter
marketbeat.com - May 20 at 5:12 AM
MarketBeat logoEnfusion (NYSE:ENFN) Stock Rating Upgraded by Zacks Investment Research
americanbankingnews.com - May 20 at 3:22 AM
MarketBeat logoEnfusion (NYSE:ENFN) Shares Gap Down to $10.00
americanbankingnews.com - May 15 at 3:12 AM
seekingalpha.com logoEnfusion, Inc. (ENFN) CEO Thomas Kim on Q1 2022 Earnings Call Transcript
seekingalpha.com - May 14 at 2:18 AM
markets.businessinsider.com logoAnalyst Ratings for Enfusion
markets.businessinsider.com - May 13 at 4:11 PM
investing.com logoEnfusion, Inc Misses Q1 EPS by 13c
investing.com - May 13 at 3:02 AM
finance.yahoo.com logoEnfusion Announces First Quarter 2022 Results
finance.yahoo.com - May 13 at 3:02 AM
finance.yahoo.com logoAn Intrinsic Calculation For Enfusion, Inc. (NYSE:ENFN) Suggests It's 28% Undervalued
finance.yahoo.com - May 12 at 2:41 PM
MarketBeat logoEnfusion (NYSE:ENFN) Downgraded to "Sell" at Zacks Investment Research
americanbankingnews.com - May 10 at 4:51 AM
MarketBeat logoZacks Investment Research Downgrades Enfusion (NYSE:ENFN) to Sell
americanbankingnews.com - May 4 at 2:26 AM
finance.yahoo.com logoEnfusion to Present at Upcoming Investor Events
finance.yahoo.com - May 2 at 8:40 PM
finance.yahoo.com logoEnfusion Announces First Quarter 2022 Earnings Release Date
finance.yahoo.com - April 29 at 9:04 PM
finance.yahoo.com logoWhy Enfusion Stock Is Plummeting Today
finance.yahoo.com - April 2 at 1:46 AM
markets.businessinsider.com logoExpert Ratings For Enfusion
markets.businessinsider.com - March 25 at 5:58 PM
benzinga.com logoStifel Maintains Buy on Enfusion, Lowers Price Target to $20
benzinga.com - March 21 at 10:52 AM
finance.yahoo.com logoEnfusion Announces Fourth Quarter 2021 Earnings Release Date
finance.yahoo.com - March 9 at 10:43 AM
finance.yahoo.com logoEnfusion Announces Tarek Hammoud’s Retirement
finance.yahoo.com - March 7 at 2:46 PM
finance.yahoo.com logoShould You Consider Investing for the Long-Term in Enfusion Inc. (ENFN)?
finance.yahoo.com - January 25 at 3:53 PM
finance.yahoo.com logoEnfusion Elevates Iris Xinwei Wang to Chief Strategy Officer and Lotte Tønsberg to Head of EMEA Sales and Executive Director, EMEA
finance.yahoo.com - January 6 at 2:29 PM
finance.yahoo.com logoBuilt In Honors Enfusion in Its Esteemed 2022 Best Places to Work Awards
finance.yahoo.com - January 5 at 1:14 PM
finance.yahoo.com logoEnfusion and Coinbase to Bring Seamless Digital Asset Connectivity to Institutions
finance.yahoo.com - December 22 at 10:35 AM
finanznachrichten.de logoEnfusion, Inc.: Enfusion Changes the Game for Portfolio Managers and Traders with Full Portfolio Transparency and Control on Mobile
finanznachrichten.de - December 18 at 7:53 PM
finance.yahoo.com logoEnfusion Changes the Game for Portfolio Managers and Traders with Full Portfolio Transparency and Control on Mobile
finance.yahoo.com - December 17 at 1:51 PM
finance.yahoo.com logoEnfusion Expands Global Footprint with New Office in Sydney, Australia
finance.yahoo.com - December 8 at 10:28 PM
finance.yahoo.com logoEnfusion Welcomes New Chief People Officer, Expands Board of Directors
finance.yahoo.com - December 7 at 4:21 PM
reuters.com logoEnfusion Inc
reuters.com - November 3 at 5:09 PM
nasdaq.com logoEnfusion, Inc. Class A Common Stock (ENFN)
nasdaq.com - October 29 at 4:45 PM
Get Enfusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.